410
Participants
Start Date
May 6, 2020
Primary Completion Date
June 17, 2025
Study Completion Date
June 17, 2025
Nicotinamide Riboside
Nicotinamide Riboside 500mg administered two times a day. Given as capsules. Duration of the trial; 52 weeks.
Placebo
Placebo drug, administered two times a day. Given as capsules. Duration of the trial; 52 weeks.
Bodø Hospital, Bodø
Arendal Hospital, Arendal
Haukeland University Hospital, Bergen
Vestre Viken Hospital, Drammen
Førde sykehus, Førde
Haugesund Hospital, Haugesund
Molde sjukehus, Molde
Akershus university hospital, Oslo
Oslo University Hospital, Oslo
University Hospital of North Norway, Tromsø
Østfold Hospital, Fredrikstad
Oslo University Hospital
OTHER
University Hospital, Akershus
OTHER
Ostfold Hospital Trust
OTHER
Førde Hospital Trust
OTHER
Helse Fonna
OTHER
Molde Hospital
OTHER
Bodø sykehus
UNKNOWN
Sorlandet Hospital HF
OTHER_GOV
Drammen sykehus
OTHER
University Hospital of Northern Norway, Tromsø, Norway
UNKNOWN
Haukeland University Hospital
OTHER